Phase I Study of Eribulin Mesylate Administered Once Every...

Clinical Cancer Research 2009 / 06 Vol. 15; Iss. 12

Phase I Study of Eribulin Mesylate Administered Once Every 21 Days in Patients with Advanced Solid Tumors

Tan, A. R., Rubin, E. H., Walton, D. C., Shuster, D. E., Wong, Y. N., Fang, F., Ashworth, S., Rosen, L. S.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
15
Language:
english
Journal:
Clinical Cancer Research
DOI:
10.1158/1078-0432.CCR-09-0360
Date:
June, 2009
File:
PDF, 208 KB
english, 2009
Conversion to is in progress
Conversion to is failed